After decades fighting Big Tobacco, Cliff Douglas now leads a foundation funded by his former adversaries
“Does it trouble you to answer that question?” one of New York’s highest paid attorneys…
Category: profiles
Meet the fetal surgeon forging CRISPR’s next frontier: curing diseases in the womb
SAN FRANCISCO — Outside, the August sun wasn’t yet visible through the thick folds of…
Carrying the torch of his slain brother, a Chicago ER doctor struggles against the violence around him
CHICAGO — Abdullah Hassan Pratt is giving a tour of a sheep heart that sits,…
JAMA’s new editor settles in, bringing open access and other changes
ST. LOUIS — It’s been eight months since Kirsten Bibbins-Domingo, a general internist, cardiovascular researcher,…
India’s lax oversight of pharmaceutical manufacturing imperils health around the world
Cough medicine tainted with ethylene glycol that killed at least 19 children in Uzbekistan in…
STAT+: Nectar bats are ‘wonderful, majestic’ and sugar-obsessed. This researcher wants to know how they stay healthy
Nectar bats may have nature’s biggest sweet tooth. Each night, the creatures scour the jungle…
CDC: Signs point to an early start for flu season, with cases already ticking up in parts of the U.S.
Before the Covid-19 pandemic emerged, influenza trackers would begin reading tea leaves around this time…
A doctor’s humbling journey treating long Covid: ‘The second we think we know what we are doing, we fall flat on our face’
I first met Wes Ely in 2016, when I wrote about ICU delirium and Ely’s…
From the Navy to a neuroscience lab: how a daughter’s diagnosis spurred her mother’s career shift
Carina Block was working an overnight shift in the U.S. Navy base in Japan, guiding…
CRISPR debuted 10 years ago, in a paper hardly anyone noticed. Jennifer Doudna reflects on the DNA scissor’s first decade
On June 28, 2012, a joint press release went out from the U.S. Department of…
Hundreds of families share a lethal inheritance. This kidney researcher hopes to break the chain
Autumn Steen roiled in the pew of the chapel, Bowditch Union Free Will Baptist Church…
He had an M.D. and a Ph.D. but didn’t match into a residency. It was the push he needed to jump into health tech
Travis Hughes had been assured by both mentors and peers that he was a front-runner…
‘We are not casting a wide enough net’: Rob Perez on how biopharma companies can help out their neighbors
If it wasn’t for a well-placed ad in the paper, Rob Perez might not have…
‘We don’t have a say’: Siobhan Wescott wants to elevate the voices of Native Americans in public health
As the first endowed professor and director of American Indian health at the University of…
STAT+: She was told ‘girls don’t do that.’ Now Margaret-Mary Wilson is a top executive at UnitedHealth Group
Long before she became a top executive at UnitedHealth Group, back in her native Nigeria,…
Denizens of ‘The Cave’ became changemakers and leaders. Here are some of its notable alumni
“All blind roads lead to Berkeley,” says Joshua Miele, a longtime resident of the Bay…
‘Where the bats hung out’: How a basement hideaway at UC Berkeley nurtured a generation of blind innovators
BERKELEY, Calif. — If, in the fall of 1987, you found yourself at the University…
The internet’s funniest doctor is in on the joke
Will Flanary’s days are spent conducting eye exams and cataract surgeries at a private practice…
STAT+: Inside the downfall of longevity crusader Aubrey de Grey — and the cult of personality that concealed a pattern of harassment
“You’ve been a bad boy,” Moses Znaimer, the bespectacled media mogul often referred to as…
STAT+: In a new role at health tech startup Maven, Neel Shah wants to make sure pregnant people aren’t ‘lost’
When celebrated Boston OB-GYN Neel Shah first learned of the chance to help build a…
Q&A: The CEO of the Alzheimer’s Association on the approval of Aduhelm — and why critics should stop dwelling on the decision
Harry Johns is ready to stop talking about whether or not the Food and Drug…
STAT+: Verily’s new big hire, Amy Abernethy, on her plans to transform clinical trials — and bring in money
As personnel moves go, the hiring of Amy Abernethy by Verily is about as big…
How Ashish Jha became network TV’s everyman expert on Covid
Chances are you’ve seen Ashish Jha during the pandemic, though you had never heard of…
Eric Lander is brilliant, connected, and controversial. Now Joe Biden wants him to ‘reinvigorate’ American science
WASHINGTON — Joe Biden’s presence at meetings of the Obama administration’s scientific advisory council sometimes…
STAT+: A former FDA chief, brimming with experience but lacking in niceties, surprises Washington by winning Biden’s trust
WASHINGTON — David Kessler is not the obvious choice for any role in the Biden…
A ‘duty to warn’: An ER doctor, shaped by war and hardship, chronicles the searing realities of Covid-19
As a Marine combat medic in Iraq’s Al-Anbar province, Cleavon Gilman saw bodies torn apart…
As a kid, his factory work paid for his dad’s cancer care. As an oncologist, his research offers more than survival
No one knows when, exactly, Mutlay Sayan was born. His mother told him it was…
With science and scripture, a Baltimore pastor is fighting Covid-19 vaccine skepticism
Terris King is finally back at Liberty Grace Church of God, surrounded by its familiar…
‘We do belong here’: The scientist behind #BlackInNeuro hopes to transform a Twitter movement into a lasting community
Angeline Dukes, a graduate student in neuroscience, didn’t intend to organize an entire movement. But…
Biotech’s new chief lobbyist says she’s a social justice advocate. Will the industry walk the walk?
WASHINGTON — Michelle McMurry-Heath doesn’t talk about biotech the way her peers do. Where other…
‘We didn’t follow through’: The official who tallied ‘lessons learned’ from Ebola weighs in on the coronavirus response
Christopher Kirchhoff knows how to assess the U.S. government’s response to a public health crisis….
After 40 years, the Alzheimer’s Association sees signs of progress against a devastating disease. Is it real?
CHICAGO — In 1979, a man named Jerome Stone, frustrated with the lack of options…
STAT Plus: Sen. Chuck Grassley takes your questions on drug prices, insulin, and innovation
WASHINGTON — Sen. Chuck Grassley has a clear position on this Congress’s priority list. “You…
STAT Plus: A Q&A with FDA’s Amy Abernethy on how the agency is grappling with digital health regulation
LAS VEGAS — The Food and Drug Administration announced this week it will hold a…